Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution
Crossref DOI link: https://doi.org/10.1007/s00277-017-3013-y
Published Online: 2017-05-27
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Yuhua
Rao, Huilan
Yan, Shumei
Wang, Fang
Wu, Qinian
Feng, Yanfen
Zhang, Yujing
Funding for this research was provided by:
Sister Institution Network Fund of the University of Texas MD Anderson Cancer Center (02210501)
License valid from 2017-05-27